Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis

Medical Clinics of North America

Volumn 84, Issue 3, 2000, Pages 719-738

  Howes, Nathan ^b   Greenhalf, William ^b   Neoptolemos, John ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN P16; PROTEIN P53; TUMOR MARKER;

BILE; CANCER RISK; CANCER SCREENING; FECES ANALYSIS; GENE MUTATION; GENETIC DISORDER; HUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS JUICE; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SERUM; TUMOR SUPPRESSOR GENE;

EID: 0034039049     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70254-6     Document Type: Article

References (94)

1. K. Akahoshi Y. Chijiiwa I. Nakano Diagnosis and staging of pancreatic cancer by endoscopic ultrasound Br J Radiol 71 1998 492 496
2. P. Anker F. Lefort V. Vasioukhin K-Ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer Gastroenterology 112 1997 1114 1120
3. S. Apple R. Hecht D. Lewin Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis Hum Pathol 30 1999 123 129
4. K.E. Bakkevold B. Arnesjo B. Kambestad Carcinoma of the pancreas and papilla of Vater—assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients Eur J Surg Oncol 18 1992 494 507
5. M. Barthet L. Portal J. Boujaoude Endoscopic ultrasonographic diagnosis of pancreatic cancer complicating pancreatic cancer Endoscopy 28 1996 487 491
6. C.M. Barton S.L. Staddon C.M. Hughes Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 94 1991 1076 1082
7. P. Berhelemy M. Bouisson J. Escourrou Identification of K-Ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer Ann Intern Med 123 1995 188 191
8. C. Berndt K. Haubold F. Wenger K-Ras mutations in stools and tissue samples from patients with malignant and non-malignant pancreatic diseases Clin Chem 44 1998 2103 2107
9. G. Berrozpe J. Schaeffer M.A. Peinado Comparative analysis of mutations in the p53 and K-Ras genes in pancreatic cancer Int J Cancer 58 1994 185 191
10. J.L. Bos Ras oncogenes in human cancer: A review Cancer Res 49 1989 4682 4689
11. J. Bourhis R. Lubin B. Roche Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma J Natl Cancer Inst 88 1996 1228 1233
12. C. Caldas S.A. Hahn da Costa L. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
13. C. Caldas S.A. Hahn R.H. Hruban Detection of K-Ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia Cancer Res 54 1994 3568 3573
14. G. Casey Y. Yamanaka H. Fries P53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis Cancer Lett 69 1993 151 160
15. A. Castells P. Puig J. Mora K-Ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance J Clin Oncol 17 1999 578 584
16. X.Q. Chen M. Stroun J.L. Magenat Microsatellite alterations in the plasma of DNA of small cell lung cancer patients Nat Med 2 1996 1033 1035
17. J.J. Cohen R.C. Duke V.A. Fadok Apoptosis and programmed cell death in immunity Annu Rev Immunol 10 1992 267 293
18. D. Coppola L. Lu J. Fruehauf Analysis of p53, p21WAF1, and TGF-beta 1 in human ductal adenocarcinoma of the pancreas: TGF-beta 1 protein expression predicts longer survival Am J Clin Pathol 110 1998 16 23
19. Del Tito B.J. H.E. Poff M.A. Novotny Automated fluorescence analysis procedure for enzymatic mutation detection Clin Chem 44 1998 731 739
20. S. Dergham M. Dugan R. Kucway Prevalence and clinical significance of combined K-Ras mutation and p53 aberration in pancreatic adenocarcinoma Int J Pancreatol 21 1997 127 143
21. Y. Endo T. Morii H. Tamura Cytodiagnosis of pancreatic malignant tumours by aspiration, under direct vision, using a duodenal fiberscope Gastroenterology 67 1974 944 951
22. M. Esteller M. Sanchez-Cespedes R. Rosell Detection of aberrant promoter hypermethylation of tumour suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 1999 67 70
23. J.M. Flaman T. Frebourg V. Moreau A simple p53 functional assay for screening cell lines, blood and tumours Genetics 92 1995 3963 3967
24. q is an early event in pancreatic ductal tumorigenesis Cancer Res 58 1999 4222 4226
25. N. Furuya S. Kawa T. Akamatsu Long-term follow up of patients with chronic pancreatitis and K-Ras gene mutation detected in pancreatic juice Gastroenterology 113 1997 593 598
26. S. Gansauge R.M. Schmid G. Muller Genetic alterations in chronic pancreatitis: Evidence for early occurrence of p53 but not K-Ras mutations Br J Surg 85 1998 337 340
27. R.A. Graham M. Bankoff R. Hediger Fine needle aspiration biopsy of pancreatic ductal adenocarcinoma: Loss of diagnostic accuracy with small tumours J Surg Oncol 55 1994 92 94
28. N. Harada F. Gansauge H. Gause Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent p21 in pancreatic cancer Br J Cancer 76 1997 299 305
29. T. Hayakawa T. Kondo T. Shibata Sensitive serum markers for detecting pancreatic cancer Cancer 61 1988 1827
30. K. Hibi R. Robinson S. Booker Molecular detection of genetic alterations in the serum of colorectal cancer patients Cancer Res 58 1998 1405 1407
31. M. Hollstein D. Sidransky B. Vogelstein p53 mutations in human cancers Science 253 1991 49 53
32. Hruban R.H. van Mansfield A.D.M. G.J.A. Offerhaus K-Ras mutations in adenocarcinoma of the pancreas Am J Pathol 143 1993 545 554
33. H. Iguchi K. Sugano N. Fukayama Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer Gastroenterology 110 1996 221 226
34. T. Iizasa T. Fujisawa Y. Saitoh Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma Cancer Immunol Immunother 46 1998 345 349
35. R. Ito K. Tamura H. Ashida Usefulness of K-Ras gene mutation at codon 12 in bile for diagnosing biliary strictures Int J Oncol 12 1998 1019 1023
36. T. Iwao A. Tsuchida K. Hanada Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas Cancer 81 1997 163 171
37. P. Johnson E. Outwater Pancreatic carcinoma versus chronic pancreatitis: Dynamic MR imaging Radiology 212 1999 213 218
38. H. Kondo K. Sugano N. Fukayama Detection of point mutations in the k-Ras oncogene at codon 12 in pure pancreatic juice for the diagnosis of pancreatic carcinoma Cancer 73 1993 1589 1594
39. S. Kondoh M. Kaino S. Okita Detection of K-ras and p53 mutations in tissue and pancreatic juice from pancreatic adenocarcinomas J Gastroenterol 33 1998 390 396
40. P. Laurent-Puig R. Lubin Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases Gut 36 1995 455 458
41. J.G. Lee J.W. Leung P.B. Cotton Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography Gastrointest Endosc 42 1995 317 320
42. M.M. Lerch I. Ellis D.C. Whitcomb Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma J Natl Cancer Inst 91 1999 723 724
43. A. Lowenfels P. Maisonneuve G. Cavallini Pancreatitis and the risk of pancreatic cancer N Engl J Med 328 1993 1433 1437
44. A. Lowenfels P. Maisonneuve E. DiMagno Hereditary pancreatitis and the risk of pancreatic cancer J Natl Cancer Inst 89 1997 442 446
45. J. Lundin S. Nordling von Boguslawsky K. Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer Oncology 53 1996 104 111
46. J. Lüttges B. Schlehe M. Menke The K-Ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic and metaplastic epithelium Cancer 85 1999 1703 1710
47. A. Malescia M.A. Tommasini C. Bonato Determination of CA19-9 antigen in serum and pancreatic juice and serum for the differential diagnosis of pancreatic adenocarcinoma and chronic pancreatitis Gastroenterology 92 1987 60
48. T. Manabe T. Miyashita G. Ohshio Small carcinomas of the pancreas Cancer 62 1988 135
49. H. Matsubayashi H. Watanabe K. Nishikura Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-Ras mutation Cancer 82 1998 651 660
50. S. Matsumoto H. Harada J. Tanaka Evaluation of cytology and tumour markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages Pancreas 6 1994 741 747
51. M. Midwinter C. Beveridge J. Wilswdon Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours Br J Surg 86 1999 189 193
52. K. Montijima T. Tsunoda T. Kanematsu Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten ras oncogene Ann Surg 214 1991 657 662
53. D.J. Moshinsky G.N. Wogan UV-induced mutagenesis of human p53 in a vector replicated in saccharomyces cerevisiae Biochemistry 94 1997 2266 2271
54. C.A. Moskaluk R.H. Hrubran S.E. Kern P16 and K-Ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140 2143
55. H.E. Mulcahy J. Lyautey C. Lederrey A prospective study of K-Ras mutations in the plasma of pancreatic cancer patients Clin Cancer Res 4 1998 271 275
56. M.F. Muller C. Meyenberger P. Bertschinger Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging Radiology 190 1994 745 751
57. H. Nawroz W. Koch P. Anker Microsatellite alterations in serum DNA of head and neck patients Nat Med 2 1996 1035 1037
58. S. Nomoto A. Nakao Y. Kasai Detection of ras gene mutations in perioperative blood with pancreatic adenocarcinoma Jpn J Cancer Res 87 1996 793 797
59. B. Palson P. Masson A. Andren-Sandberg Tumour marker CA50 levels compared to signs and symptoms in the diagnosis of pancreatic cancer Eur J Surg Oncol 23 1997 151 161
60. N.S. Pellagata F. Sessa B. Renault K-Ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumours progress through different genetic lesions Cancer Res 54 1994 1556 1560
61. S. Phoa W. Reeders A. Rauws Spiral computed tomography for preoperative staging of potentially resectable carcinoma of the pancreatic head Br J Surg 86 1999 789 794
62. C. Rall Y. Yan Graeme Cook F. K-Ras and p53 mutations in pancreatic ductal adenocarcinoma Pancreas 12 1996 7 10
63. G.J. Riggins K.W. Kinzler B. Vogelstein Frequency of smad4 gene mutations in human cancer Cancer Res 57 1997 2578 2580
64. J.A. Rivera C.J.N. Rall F. Graeme-Cook Analysis of K-Ras oncogene mutations in chronic pancreatitis and ductal hyperplasia Surgery 121 1997 42 49
65. T. Rosch R. Lorenz C. Braig Endoscopic ultrasound in pancreatic tumour diagnosis Gastrointest Endosc 37 1991 347 352
66. E. Rozenblum M. Schutte M. Goggins Tumour suppressive pathways in pancreatic cancer Cancer Res 57 1997 1731 1734
67. B.A. Ruggeri L. Huang D. Berger Molecular pathology of primary and metastatic ductal pancreatic lesions Cancer 79 1997 700 716
68. F. Safi W. Schlosser S. Falkenreck CA19-9 serum course and prognosis in pancreatic cancer Int J Pancreatol 20 1996 155 161
69. J.S. Savill A.H. Wyllie J.E. Henson Macrophage phagocytosis of aging neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages J Clin Invest 83 1989 875 865
70. A. Scarpa P. Capelli K. Mukai Pancreatic adenocarcinoma frequently show p53 gene mutations Am J Pathol 142 1993 1534 1541
71. B.K. Schaeffer S. Glasner E. Kuhlmann Mutated c-K-Ras in small pancreatic adenocarcinomas Pancreas 9 1994 161 165
72. M. Schutte R.H. Hruban J. Geradts Abrogation of the Rb/p16 tumour-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126 3130
73. M. Schutte H. Ralph L. Hedrick DPC4 in various tumour types Cancer Res 56 1996 2527 2530
74. E. Seifert Y. Urakami K. Elster Duodenoscopic guided biopsy of the biliary and pancreatic duct Endoscopy 9 1977 154 161
75. B. Shapiro M. Chakrabarty E.M. Cohn Determination of circulating DNA levels in patients with benign or malignant disease Cancer 51 1983 2116 2120
76. D. Sidransky T. Tokino S.R. Hamilton Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours Science 256 1992 102 105
77. P.D. Sturm R.H. Hruban T.B. Ramsoekh The potential diagnostic use of K-Ras codon 12 and p53 alterations in brush cytology from the pancreatic head region J Pathol 186 1998 247 253
78. K. Sugio K. Molberg J. Albores-Saavedra K-Ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers Int J Pancreatol 21 1997 205 217
79. H. Suwa N. Ohshio N. Okada Clinical significance of serum p53 antigen in patients with pancreatic carcinomas Gut 40 1997 647 653
80. M. Tada M. Ohashi Y. Shiratori Analysis of K-Ras mutation in hyperplastic duct cells of the pancreas without pancreatic disease Gastroenterology 110 1996 227 231
81. M. Tada M. Omata S. Kawai Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Res 53 1993 2472 2474
82. M. Tada T. Teratani Y. Komatsu Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma Dig Dis Sci 43 1998 15 20
83. Van Laethem J.L. K-Ras mutations in chronic pancreatitis: Which discriminating ability for malignant potential Cell and Molecular Biology of Pancreatic Carcinoma 1999 New York Academy of Sciences New York 210 218
84. Van Laethem J.L. V. Bourgeois J. Parma Relative contribution of K-Ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases Gastrointest Endosc 47 1998 479 485
85. T. Wao K. Hanada A. Tsuchida The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushings with special attention to p53 mutations Cancer 82 1998 1487 1494
86. H. Watanabe N. Sawabu Y. Songur Detection of K-ras point mutations at codon 12 in pure pancreatic juice by PCR-RFLP analysis Pancreas 1 1996 18 24
87. H. Watanabe Y. Yamaguchi A. Ha Quantitative determination of K-Ras mutations in pancreatic juice for the diagnosis of pancreatic cancer using hybridisation protection assay Pancreas 17 1998 341 347
88. F. Wenger J. Zieren F. Peter K-Ras mutations in tissue and stool samples from patients with cancer and chronic pancreatitis Langenbecks Arch Surg 384 1998 181 186
89. R. Wilentz C. Chung P. Sturm K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma Cancer 82 1998 96 103
90. R.E. Wilentz J. Geradts R. Maynard Inactivation of the p16 (INK4A) tumour suppressor gene in pancreatic duct lesions: Loss of intranuclear expression Cancer Res 58 1998 4710 4714
91. T. Yamada S. Nakamori H. Ohzato Detection of K-Ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features Clin Cancer Res 4 1998 1527 1532
92. Y. Yamaguchi H. Watanabe S. Yrdiran Detection of mutations of p53 tumour suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: Comparison with K-ras mutation Clin Cancer Res 5 1999 1147 1153
93. K. Yamashita Y. Kida H. Shinoda K-Ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytological examination Jpn J Cancer Res 90 1998 240 248
94. A. Yanagisawa K. Ohtake K. Ohnishi Frequent c Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation Cancer Res 53 1993 953 956